| Issue Date | Title | Author(s) |
| 2025 | Comparison of Two Alternative Sequences With Cabazitaxel and 177lu-Psma in Metastatic Castration-Resistant Prostate Cancer: a Retrospective Multicenter Study (lucas) | Bolek, H.; Yazgan, S.C.; Ceylan, F.; Esteban-Villarrubia, J.; Arslan, C. ; Kuş, T.; Ürün, Y. |
| 2025 | Evaluating the Prognostic Role of Glucose-To Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors in First Line: a Study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC) | Bolek, H.; Kuzu, O.F.; Sertesen Camoz, E.; Sim, S.; Sekmek, S.; Karakas, H.; Urun, Y. |
| 2025 | Evaluating the Prognostic Role of Glucose-To Ratio in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors in First Line: a Study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC) | Bolek, H.; Kuzu, O.F.; Sertesen Camoz, E.; Sim, S.; Sekmek, S.; Karakas, H.; Urun, Y. |
| 2025 | Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium | Bolek, H.; Kuzu, O.F.; Sertesen Camoz, E.; Sim, S.; Sekmek, S.; Karakas, H.; Urun, Y. |
| 2025 | Sunitinib in Metastatic Renal Cell Carcinoma: Clinical Outcomes Across Risk Groups in a Turkish Oncology Group Kidney Cancer Consortium | Bolek, H.; Kuzu, O.F.; Sertesen Camoz, E.; Sim, S.; Sekmek, S.; Karakas, H.; Urun, Y. |
